UPK2 and urothelial carcinoma: Consistent with the basal differentiation in Kmt2c/d KO urothelium, the urothelial carcinoma models exhibited basal phenotype, corroborated by KRT5 positivity and loss of UPK2 by IHC (Extended Data Fig. 8d).